SCHEDULE 13G

Company

Altimmune, Inc.

Filed

August 5, 2005

Accession Number

0000950134-05-015015

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →